Baclofen for Children With Rumination Syndrome

Description

The goal of this clinical trial is to learn about baclofen in pediatric patients with rumination syndrome. The main question it aims to answer is whether baclofen is effective in treating children with rumination syndrome. Participants will be asked to take baclofen or placebo for 4 weeks and fill out surveys regarding symptoms.

Conditions

Rumination Syndrome

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this clinical trial is to learn about baclofen in pediatric patients with rumination syndrome. The main question it aims to answer is whether baclofen is effective in treating children with rumination syndrome. Participants will be asked to take baclofen or placebo for 4 weeks and fill out surveys regarding symptoms.

A Randomized Controlled Pilot Trial of Baclofen for Children With Rumination Syndrome

Baclofen for Children With Rumination Syndrome

Condition
Rumination Syndrome
Intervention / Treatment

-

Contacts and Locations

Columbus

Nationwide Children's Hospital, Columbus, Ohio, United States, 73205

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Children 4-18 years of age who meets Rome IV diagnostic criteria for rumination syndrome and are see at NCH GI clinic
  • * Patients who have contraindications to baclofen due to medical history and/or current medications
  • * Patients who are non- English speaking
  • * Patients who are pregnant

Ages Eligible for Study

4 Years to 18 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Nationwide Children's Hospital,

Study Record Dates

2024-07